Medicare coverage for PEMGARDA typically depends on specific patient eligibility criteria, Part B or Part D plan structures, and clinical administration settings where the intravenous infusion is delivered. Because it is administered as a clinical infusion procedure by a qualified healthcare provider for pre-exposure prophylaxis in high-risk immunocompromised patients, coverage and out-of-pocket copayments can vary across original Medicare and Medicare Advantage plans. Beneficiaries are encouraged to consult their specific insurance plan providers or medical billing specialists to verify prior authorization requirements and coverage policies before scheduling treatment.